blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1715892

EP1715892 - METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  13.05.2011
Database last updated on 11.09.2024
Most recent event   Tooltip13.05.2011Withdrawal of applicationpublished on 15.06.2011  [2011/24]
Applicant(s)For all designated states
ChemoCentryx, Inc.
850 Maude Avenue Mountain View
California 94043 / US
[2006/44]
Inventor(s)01 / BURNS, Jennifer
500 Walnut Street
Royersford, PA 19468 / US
02 / SUMMERS, Bretton
1045 Mission Street, 418
San Francisco, CA 94103-5816 / US
03 / WANG, Yu
235 Isleford Lane
Redwood City, CA 94065 / US
04 / HOWARD, Maureen
12700 Viscaino Road
Los Altos, CA 94022 / US
05 / SCHALL, Thomas
563 Homer Avenue
Palo Alto, CA 94301 / US
06 / MIAO, Zhenhua
7070 Rainbow Drive, 2
San Jose, CA 95129 / US
 [2006/44]
Representative(s)Broughton, Jon Philip, et al
Avidity IP
Merlin House
Falconry Court
Baker's Lane, Epping
Essex CM16 5DQ / GB
[N/P]
Former [2006/44]Broughton, Jon Philip, et al
HLBBshaw Merlin House Falconry Court Baker's Lane
Epping, Essex CM16 5DQ / GB
Application number, filing date05726389.902.02.2005
[2006/44]
WO2005US03521
Priority number, dateUS20040541849P03.02.2004         Original published format: US 541849 P
US20040598958P04.08.2004         Original published format: US 598958 P
US20040626195P08.11.2004         Original published format: US 626195 P
[2006/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005074645
Date:18.08.2005
Language:EN
[2005/33]
Type: A2 Application without search report 
No.:EP1715892
Date:02.11.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 18.08.2005 takes the place of the publication of the European patent application.
[2006/44]
Search report(s)International search report - published on:US22.12.2005
(Supplementary) European search report - dispatched on:EP11.06.2008
ClassificationIPC:A61K39/395, A61K38/00, A61P17/02, A61P19/02, A61P35/00, A61P37/00, C07D207/00, C07K16/28
[2008/28]
CPC:
A61K38/195 (EP,US); A61K45/06 (EP,US); A61P17/02 (EP);
A61P19/02 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P43/00 (EP); A61P9/00 (EP); C07K16/2866 (EP,US) (-)
C-Set:
A61K38/195, A61K2300/00 (EP,US)
Former IPC [2006/44]A61K39/395, A61K38/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/44]
Extension statesAL18.08.2006
BA18.08.2006
HR18.08.2006
LV18.08.2006
MK18.08.2006
YU18.08.2006
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR MODULATION DER ANGIOGENESE[2006/44]
English:METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS[2006/44]
French:PROCEDES ET COMPOSITIONS PERMETTANT DE MODULER L'ANGIOGENESE[2006/44]
Entry into regional phase18.08.2006National basic fee paid 
18.08.2006Search fee paid 
18.08.2006Designation fee(s) paid 
18.08.2006Examination fee paid 
Examination procedure18.08.2006Examination requested  [2006/44]
24.10.2006Amendment by applicant (claims and/or description)
08.01.2009Despatch of a communication from the examining division (Time limit: M06)
25.08.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.09.2009Reply to a communication from the examining division
27.01.2010Despatch of a communication from the examining division (Time limit: M06)
09.06.2010Reply to a communication from the examining division
12.07.2010Despatch of a communication from the examining division (Time limit: M06)
24.01.2011Reply to a communication from the examining division
09.05.2011Application withdrawn by applicant  [2011/24]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.01.2009
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
08.09.2009Request for further processing filed
08.09.2009Full payment received (date of receipt of payment)
Fees paidRenewal fee
18.08.2006Renewal fee patent year 03
25.02.2008Renewal fee patent year 04
09.02.2009Renewal fee patent year 05
08.02.2010Renewal fee patent year 06
08.02.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9947158  (UNIV BRITISH COLUMBIA [CA], et al) [A] 1-17 * the whole document *;
 [X]US2002107195  (GUPTA SHALLEY K [US]) [X] 1-3 * page 14 * * claims 1-6 *;
 [A]WO02094261  (KUREHA CHEMICAL IND CO LTD [JP], et al) [A] 13,17 * & EP1389460 (2004-02-18); pages 116-117; figures 6,7 *;
 [PX]WO2004058705  (CHEMOCENTRYX [US]) [PX] 1,2,7,10 * page 1 - page 3 * * page 25, paragraph 1 * * page 28, paragraphs 2,3 * * page 109, paragraph 2 - page 111, paragraph 1 *;
 [PX]WO2004062591  (UNIV OREGON HEALTH & SCIENCE [US], et al) [PX] 1,2,7,8 * page 35, lines 4-6 * * page 47, lines 16-29 * * page 48 - page 52 * * tables 1-4 *;
 [X]  - SALVUCCI OMBRETTA ET AL, "Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1.", BLOOD 15 APR 2002, (20020415), vol. 99, no. 8, ISSN 0006-4971, pages 2703 - 2711, XP002481675 [X] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1182/blood.V99.8.2703
 [A]  - PHILLIPS RODERICK J ET AL, "The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 15 JUN 2003, (20030615), vol. 167, no. 12, ISSN 1073-449X, pages 1676 - 1686, XP002481676 [A] 1-17 * page 1682 - page 1683 * * figures 10,11 *

DOI:   http://dx.doi.org/10.1164/rccm.200301-071OC
 [A]  - MUELLER ANJA ET AL, "Involvement of chemokine receptors in breast cancer metastasis", NATURE, NATURE PUBLISHING GROUP, LONDON, (20010301), vol. 410, no. 6824, ISSN 0028-0836, pages 50 - 56, XP002292390 [A] 1-17 * page 51, column R, paragraph 5; figure 4 *

DOI:   http://dx.doi.org/10.1038/35065016
 [A]  - PROUDFOOT A E I ET AL, "STRATEGIES FOR CHEMOKINE ANTAGONISTS AS THERAPEUTICS", SEMINARS IN IMMUNOLOGY, W.B. SAUNDERS COMPANY, PA, US, (20030101), vol. 15, no. 1, ISSN 1044-5323, pages 57 - 65, XP001156225 [A] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/S1044-5323(02)00128-8
 [A]  - SALCEDO ROSALBA ET AL, "Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses.", MICROCIRCULATION (NEW YORK, N.Y. : 1994) JUN 2003, (200306), vol. 10, no. 3-4, ISSN 1073-9688, pages 359 - 370, XP008091927 [A] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.mn.7800200
 [T]  - BURNS JENNIFER M ET AL, "A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, (20060901), vol. 203, no. 9, ISSN 0022-1007, pages 2201 - 2213, XP002447048 [T] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1084/jem.20052144
 [T]  - MIAO ZHENHUA ET AL, "CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (200710), vol. 104, no. 40, ISSN 0027-8424, pages 15735 - 15740, XP002481677 [T] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.0610444104
International search[X]US2004019917  (BARNES THOMAS M [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.